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[INTRODUCTION] Among various kinds of cancers the pancreatic cancer has currently the lowest 
survival rate for five years of the patient because of permeation and metastasis at an early stage. 
Photodynamic therapy (PDT) is expected as most promising technique because of low energy 
treatment. Though local curative effects of PDT are quite high for superficial cancers, there are few 
reports for cancer located in deep bodies. In this study PDT was performed on several human 
pancreatic cancer cell lines using Talaporfin as a photosensory material, and the cytotoxic effect was 
evaluated under various conditions. Furthermore, by adding an inhibitor for various uptake of 
Talaporfin, the intracellular shift mechanism was investigated. 
 
[METHOD] The four pancreas cancer cells strain (MiaPaCa-2, AsPC-1, Panc-1, SUIT-2) were used. 
In the PDT experiment, 2.5×10⁴cells were seeded on a 96 well-plate, followed by the addition of 
100µL/1well of serum-free medium doped with 30mg/mL of Talaporfin. The laser light of 664nm and 
power density of 2.5~10.0J/cm² was irradiated at 2, 4 and 6 hrs after addition of Talaporfin. Adding 
20µL live cell measurement reagent MTS, the cell viability was evaluated by colorimetric analysis of 
a plate reader. In addition, an endocytosis inhibitor which inhibits the uptake pathway of Talaporfin 
was added, and comparison with the normal PDT effect was performed.   
 
[RESULTS] The survival rate largely decreased in all cell strain (Fig.1), which supports the 
effectiveness of PDT on pancreatic cancer cell. In addition, it was suggested that the decrease in cell 
survival rate depended on the Talaporfin add time and the laser power density. SUIT-2 was the lowest 
at 16.5% and MiaPaCa-2 was the highest at 34.8%. The PDT results using endocytosis inhibitors (Fig. 
2) show inhibitor Dynasore, which inhibits clathrin endocytosis, did not reduce the survival rate in all 
cell lines. AsPC-1 and MiaPaCa-2 did not reduce survival rate with any inhibitor. Hence, it was 
suggested that caveolae by the inhibitors Methyl- β-cyclodextrin and Genistein, lipid rough and 
endocytosis, and clathrin endocytosis by Sucrose and Dynasore are involved in the Talaporfin uptake. 
 
[SUMMARY] The PDT results suggested that Panc-1 was effective for PDT when comparing poorly 
differentiated Panc-1 and moderately differentiated AsPC-1. In the endocytosis inhibition experiment, 
AsPC-1 and MiaPaCa-2 decreased the uptake of Talaporfin with all the inhibitors, and the PDT effect 
could not be confirmed. However, since the PDT effect was confirmed in Panc-1 and SUIT-2, it is 
necessary to conduct experiments using different pathway inhibitors to confirm the migration pathway 
of Talaporfin. 






Fig.1 Survival rate change according to the dosage time  
and the irradiation power, of Talaporfin in various cell strain. 
 
 
Fig.2 PDT effect of various endocytosis inhibitors. 
 
 
  
